CORT Corcept Therapeutics Incorporated

NASDAQ
$67.79

Corcept Therapeutics Incorporated (CORT) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with CORT's own trailing one-year pace, with 88% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 6 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
6
37 transactions
Purchases
$0
0 shares
Sales
$27.8M
249,435 shares
Net activity
-$27.8M
purchases less sales

How much of that selling was preplanned? 88% planned / 12% discretionary

10b5-1 plan sales $24.5M 36 transactions · 222,750 shares
Discretionary sales $3.3M 1 transaction · 26,685 shares

Largest single sale: $3.3M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: March 17, 2026 , by BAKER G LEONARD JR .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Swisher Daniel N JR Director Sell 10b5-1 1,500 $74.07 $111.1K None left
Maduck Sean 2 fills Other Sell 10b5-1 13,159 $82.25 $1.1M 14,480 −47.6% of holding
Maduck Sean Other Sell 10b5-1 11,841 $81.42 $964.1K 9,938 −54.4% of holding
Vieira Roberto Wandenkolk 2 fills President, Oncology Sell 10b5-1 8,333 $80.89 $674.1K 5,622 −59.7% of holding
WILSON JAMES N 3 fills Director Sell 10b5-1 10,000 $114.81 $1.1M 1,057,889 −0.9% of holding
Maduck Sean 2 fills See Remarks Sell 10b5-1 24,587 $116.28 $2.9M 18,682 −56.8% of holding
Lyon Joseph Douglas 2 fills See Remarks Sell 10b5-1 9,190 $116.13 $1.1M 10,427 −46.8% of holding
Vieira Roberto Wandenkolk 3 fills President, Oncology Sell 10b5-1 8,333 $116.10 $967.4K 11,179 −42.7% of holding
Lyon Joseph Douglas See Remarks Sell 10b5-1 810 $115.40 $93.5K 5,683 −12.5% of holding
Maduck Sean See Remarks Sell 10b5-1 413 $115.54 $47.7K 9,938 −4% of holding
Vieira Roberto Wandenkolk President, Oncology Sell 10b5-1 296 $100.82 $29.8K 3,946 −7% of holding
WILSON JAMES N 3 fills Director Sell 10b5-1 10,000 $110.69 $1.1M 1,067,743 −0.9% of holding
Lyon Joseph Douglas 2 fills See Remarks Sell 10b5-1 10,000 $113.49 $1.1M 7,871 −56% of holding
Vieira Roberto Wandenkolk 7 fills President, Oncology Sell 10b5-1 58,333 $110.76 $6.5M 38,975 −59.9% of holding
Maduck Sean 3 fills See Remarks Sell 10b5-1 25,000 $114.43 $2.9M 23,025 −52.1% of holding
Park Kimberly Director Sell 26,685 $122.55 $3.3M None left
Maduck Sean 2 fills See Remarks Sell 10b5-1 30,955 $125.58 $3.9M 15,625 −66.5% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.